CRDLCardiol Therapeutics Inc.同业对比
Cardiol Therapeutics Inc. 与SIC 2836 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRDL本股 | $187M#6 | — | — | — | — | — | — | — | — | — | 69.2%#2 | — |
| AUTL | $518M#3 | — | 6.9x#2 | 6.9x#2 | 644.9%#1 | -30.3%#11 | -358.9%#5 | -384.2%#8 | — | — | 44.1%#4 | — |
| BNTX | $24.2B#1 | — | — | — | — | — | — | — | — | — | -0.2%#6 | — |
| CGEN | $234M#5 | 6.5x#2 | 2.3x#1 | 3.2x#1 | 161.1%#2 | 348.4%#1 | 43.1%#1 | 34.4%#2 | — | — | 84.4%#1 | — |
| CKDXF | — | — | — | — | -80.0%#9 | 26.1%#4 | -623048.0%#10 | — | — | — | — | — |
| CLDWW | — | — | — | — | — | 10.1%#7 | -44977.8%#9 | -635.4%#9 | — | — | — | — |
| CLLS | — | — | — | — | 75.8%#3 | -83.9%#12 | -45.3%#2 | -89.1%#4 | — | — | -52.0%#7 | — |
| CPMV | — | — | — | — | — | 25.4%#6 | — | — | — | — | — | — |
| CYVNY | — | — | — | — | -80.0%#9 | 26.1%#4 | -623048.0%#10 | — | — | — | — | — |
| DBVT | $3.7B#2 | — | 22.9x#3 | 652.7x#3 | 35.8%#4 | -29.0%#9 | -2609.2%#6 | -91.6%#5 | — | — | 29.4%#5 | — |
| DBVTF | — | — | — | — | 35.8%#4 | -29.0%#9 | -2609.2%#6 | -91.6%#5 | — | — | — | — |
| DNABW | — | — | — | — | -25.1%#7 | 42.8%#3 | -185.3%#3 | -0.1%#3 | — | — | — | — |
| ELUT | — | 0.9x#1 | — | — | -15.0%#6 | 198.9%#2 | -218.9%#4 | 339.0%#1 | -122.6%#1 | — | — | — |
| ENTX | $512M#4 | 8.5x#3 | 70.5x#4 | 12202.4x#4 | -76.8%#8 | -19.9%#8 | -27450.0%#8 | -157.4%#7 | — | — | 62.2%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-19。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议